These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28392046)

  • 1. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.
    Jamilloux Y; Cohen-Aubart F; Chapelon-Abric C; Maucort-Boulch D; Marquet A; Pérard L; Bouillet L; Deroux A; Abad S; Bielefeld P; Bouvry D; André M; Noel N; Bienvenu B; Proux A; Vukusic S; Bodaghi B; Sarrot-Reynauld F; Iwaz J; Amoura Z; Broussolle C; Cacoub P; Saadoun D; Valeyre D; Sève P;
    Semin Arthritis Rheum; 2017 Oct; 47(2):288-294. PubMed ID: 28392046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
    Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
    JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.
    Vallet H; Riviere S; Sanna A; Deroux A; Moulis G; Addimanda O; Salvarani C; Lambert M; Bielefeld P; Seve P; Sibilia J; Pasquali J; Fraison J; Marie I; Perard L; Bouillet L; Cohen F; Sene D; Schoindre Y; Lidove O; Le Hoang P; Hachulla E; Fain O; Mariette X; Papo T; Wechsler B; Bodaghi B; Rigon MR; Cacoub P; Saadoun D;
    J Autoimmun; 2015 Aug; 62():67-74. PubMed ID: 26162757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.
    Crommelin HA; van der Burg LM; Vorselaars AD; Drent M; van Moorsel CH; Rijkers GT; Deneer VH; Grutters JC
    Respir Med; 2016 Jun; 115():72-7. PubMed ID: 27215507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of refractory neurosarcoidosis treated with infliximab.
    Cohen Aubart F; Bouvry D; Galanaud D; Dehais C; Mathey G; Psimaras D; Haroche J; Pottier C; Hie M; Mathian A; Devilliers H; Nunes H; Valeyre D; Amoura Z
    J Neurol; 2017 May; 264(5):891-897. PubMed ID: 28260120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
    Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
    Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT.
    Marquet A; Chapelon-Abric C; Maucort-Boulch D; Cohen-Aubart F; Pérard L; Bouillet L; Abad S; Bielefeld P; Bouvry D; André M; Noël N; Bienvenu B; Proux A; Vukusic S; Bodaghi B; Sarrot-Reynaud F; Iwaz J; Broussolle C; Saadoun D; Jamilloux Y; Valeyre D; Sève P;
    Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):74-80. PubMed ID: 32476825
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.
    Vallet H; Seve P; Biard L; Baptiste Fraison J; Bielefeld P; Perard L; Bienvenu B; Abad S; Rigolet A; Deroux A; Sene D; Perlat A; Marie I; Feurer E; Hachulla E; Fain O; Clavel G; Riviere S; Bouche PA; Gueudry J; Pugnet G; Le Hoang P; Resche Rigon M; Cacoub P; Bodaghi B; Saadoun D;
    Arthritis Rheumatol; 2016 Jun; 68(6):1522-30. PubMed ID: 27015607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ocular sarcoidosis.
    Baughman RP; Lower EE; Ingledue R; Kaufman AH
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):26-33. PubMed ID: 23311120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis.
    Drent M; Cremers JP; Jansen TL; Baughman RP
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):91-107. PubMed ID: 25078637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory sarcoidosis responding to infliximab.
    Roberts SD; Wilkes DS; Burgett RA; Knox KS
    Chest; 2003 Nov; 124(5):2028-31. PubMed ID: 14605086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
    Thielen AM; Barde C; Saurat JH; Laffitte E
    Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.
    Chapelon-Abric C; Saadoun D; Biard L; Sene D; Resche-Rigon M; Hervier B; Costedoat-Chalumeau N; Drier A; Leger JM; Cacoub P
    Clin Exp Rheumatol; 2015; 33(4):509-15. PubMed ID: 26120779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
    Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
    Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.
    Lahmer T; Knopf A; Lanzl I; Heemann U; Thuermel K
    Rheumatol Int; 2012 Aug; 32(8):2367-70. PubMed ID: 21644042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
    Sakkat A; Cox G; Khalidi N; Larche M; Beattie K; Renzoni EA; Morar N; Kouranos V; Kolb M; Hambly N
    Respir Res; 2022 Mar; 23(1):54. PubMed ID: 35264154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
    Torrente-Segarra V; Acosta Pereira A; Morla R; Ruiz JM; Clavaguera T; Figuls R; Corominas H; Geli C; Roselló R; de Agustín JJ; Alegre C; Pérez C; García A; Rodríguez de la Serna A
    Reumatol Clin; 2016; 12(6):319-322. PubMed ID: 26831256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab.
    Cruz BA; Reis DD; Araujo CA;
    Rheumatol Int; 2007 Oct; 27(12):1181-3. PubMed ID: 17520259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.